Core Insights - The company, Shangrong Medical, closed at 3.9 yuan, marking a 2.90% increase, with a rolling PE ratio of 147.45, the lowest in 16 days, and a total market capitalization of 3.297 billion yuan [1][2] - The average PE ratio in the medical device industry is 53.65, with a median of 37.22, placing Shangrong Medical at 110th in the industry ranking [1][2] - As of March 31, 2025, the number of shareholders decreased by 621 to 58,323, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Company Overview - Shangrong Medical specializes in the production and sales of medical products, medical services, and health industry operations [1] - The company is recognized for introducing clean technology into hospital operating rooms and has received multiple honors, including national key new product recognition and a second-class award for scientific and technological progress from the Shenzhen government [1] - The company holds over 180 patents, contributing to its continuous development and innovation [1] Financial Performance - In the first quarter of 2025, the company reported revenue of 280 million yuan, a year-on-year increase of 1.30%, and a net profit of 13.9642 million yuan, reflecting a year-on-year growth of 0.58% [2] - The sales gross margin for the same period was 15.27% [2]
尚荣医疗收盘上涨2.90%,滚动市盈率147.45倍,总市值32.97亿元